Back to trials
not yet recruiting
Not Applicable

NCT07563725

Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging)

Sponsored by National Institute of Cardiology, Laranjeiras, Brazil

Summary

Rising life expectancy worldwide challenges public health due to increased cardiovascular disease linked to vascular aging, where microvascular dysfunction serves as an early indicator of system-wide inflammation, or "inflammaging". The proposed study aims to validate non-invasive, high-resolution techniques, such as Laser Speckle Contrast Imaging, to identify early endothelial senescence biomarkers and map their correlation with metabolic, inflammatory, and anthropometric profiles to advance personalized, preventive translational medicine.

Eligibility Criteria

Inclusion Criteria: * Absence of symptoms and history of cardiovascular and cerebrovascular diseases. * Baseline blood pressure levels within the normal range (\< 140/90 mmHg, according to WHO criteria) and absence of use of antihypertensive medications. Exclusion Criteria: * Diabetes Mellitus: Fasting blood glucose ≥ 126 mg/dL or use of hypoglycemic agents. * Smoking: Active or quit less than 5 years ago. * Inflammatory Diseases: Autoimmune diseases, active neoplasms, or acute infectious processes. * Surgery or trauma in the last 60 days. * Renal Dysfunction: Chronic renal failure (estimated by eGFR \< 60 mL/min/1.73m²). * Medication Use: Chronic use of corticosteroids, immunosuppressants, or drugs with direct action on vascular reactivity (e.g., continuous use of nitrates).

Locations (1)

Eduardo Tibiriçá

Rio de Janeiro, Brazil

Why you can trust this information
Registry sourcesclinicaltrials_gov
Source last updated5/4/2026
Clintriva indexed9/27/2026, 9:22:12 PM
Registry records1
Relationships needing review0

Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.

Interested in this trial?

Express your interest and we'll connect you with the trial team.

Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.

Quick Facts
Start DateJun 1, 2026
CompletionDec 1, 2029
Enrollment0/62
CountryBrazil

Conditions

Aging Problems
View on registry
Clintriva
GDPR Controls Mapped HIPAA Safeguards Mapped NHS DSP Controls Mapped SOC 2 Controls Mapped

© 2026 Clintriva. All rights reserved.